NO991995L - Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof - Google Patents
Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereofInfo
- Publication number
- NO991995L NO991995L NO991995A NO991995A NO991995L NO 991995 L NO991995 L NO 991995L NO 991995 A NO991995 A NO 991995A NO 991995 A NO991995 A NO 991995A NO 991995 L NO991995 L NO 991995L
- Authority
- NO
- Norway
- Prior art keywords
- vaccine compositions
- amino acid
- nucleic acid
- sequences related
- heliobacter pylori
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Rekombinant eller vesentlig rene fremstillinger av H. pylori polypeptider er beskrevet. Nukelinsyrene som koder for polypeptider er også beskrevet. H. pylori polypeptider er nyttige i diagnostikk og vaksinesammensetninger.Recombinant or substantially pure preparations of H. pylori polypeptides are described. The nucleic acids encoding polypeptides are also described. H. pylori polypeptides are useful in diagnostics and vaccine compositions.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73915096A | 1996-10-28 | 1996-10-28 | |
US75973996A | 1996-12-06 | 1996-12-06 | |
US89192897A | 1997-07-14 | 1997-07-14 | |
PCT/US1997/019575 WO1998018323A1 (en) | 1996-10-28 | 1997-10-28 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991995D0 NO991995D0 (en) | 1999-04-27 |
NO991995L true NO991995L (en) | 1999-06-28 |
Family
ID=27419246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991995A NO991995L (en) | 1996-10-28 | 1999-04-27 | Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0973394A4 (en) |
JP (1) | JP2001504329A (en) |
KR (1) | KR20000052831A (en) |
CN (1) | CN1235513A (en) |
AR (1) | AR009600A1 (en) |
AU (1) | AU734052B2 (en) |
BR (1) | BR9712587A (en) |
CA (1) | CA2265523A1 (en) |
EE (1) | EE9900176A (en) |
ID (1) | ID22065A (en) |
IL (1) | IL129397A0 (en) |
IS (1) | IS5005A (en) |
NO (1) | NO991995L (en) |
NZ (1) | NZ334568A (en) |
PL (1) | PL333169A1 (en) |
SA (1) | SA98180918A (en) |
SK (1) | SK34699A3 (en) |
TR (1) | TR199900940T2 (en) |
WO (1) | WO1998018323A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003824A1 (en) * | 1993-07-27 | 1995-02-09 | Csl Limited | Treatment of h. pylori associated gastroduodenal disease |
US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
DE19730425A1 (en) | 1997-07-16 | 1999-01-21 | Henkel Teroson Gmbh | Heat-curing laundry-resistant shell sealant |
WO2000006743A2 (en) * | 1998-07-27 | 2000-02-10 | Connaught Laboratories Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
SE9901548D0 (en) * | 1999-04-29 | 1999-04-29 | Astra Ab | Helicobacter pylori antigens |
GB9914945D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
CN101532001A (en) | 2000-03-08 | 2009-09-16 | 诺维信公司 | Variants with altered properties |
GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
GB0010370D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
US9359627B2 (en) | 2011-03-17 | 2016-06-07 | National University Corporation Mie University | Antibody production method |
US10828358B2 (en) * | 2015-12-14 | 2020-11-10 | Technische Universität München | Helicobacter pylori vaccines |
CN115724922B (en) * | 2022-07-19 | 2023-08-22 | 四川大学华西医院 | Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof |
CN115581201A (en) * | 2022-08-26 | 2023-01-10 | 云南省农业科学院花卉研究所 | Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9300139L (en) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Preparation of a new drug |
-
1997
- 1997-10-28 CN CN97199233A patent/CN1235513A/en active Pending
- 1997-10-28 AR ARP970105002A patent/AR009600A1/en not_active Application Discontinuation
- 1997-10-28 CA CA002265523A patent/CA2265523A1/en not_active Abandoned
- 1997-10-28 JP JP52071098A patent/JP2001504329A/en active Pending
- 1997-10-28 AU AU50933/98A patent/AU734052B2/en not_active Ceased
- 1997-10-28 TR TR1999/00940T patent/TR199900940T2/en unknown
- 1997-10-28 ID IDW990160A patent/ID22065A/en unknown
- 1997-10-28 KR KR1019990703660A patent/KR20000052831A/en not_active Application Discontinuation
- 1997-10-28 IL IL12939797A patent/IL129397A0/en unknown
- 1997-10-28 EP EP97913847A patent/EP0973394A4/en not_active Withdrawn
- 1997-10-28 SK SK346-99A patent/SK34699A3/en unknown
- 1997-10-28 BR BR9712587-3A patent/BR9712587A/en not_active IP Right Cessation
- 1997-10-28 EE EEP199900176A patent/EE9900176A/en unknown
- 1997-10-28 NZ NZ334568A patent/NZ334568A/en unknown
- 1997-10-28 WO PCT/US1997/019575 patent/WO1998018323A1/en not_active Application Discontinuation
- 1997-10-28 PL PL97333169A patent/PL333169A1/en unknown
-
1998
- 1998-02-28 SA SA98180918A patent/SA98180918A/en unknown
-
1999
- 1999-03-18 IS IS5005A patent/IS5005A/en unknown
- 1999-04-27 NO NO991995A patent/NO991995L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR199900940T2 (en) | 1999-09-21 |
EP0973394A1 (en) | 2000-01-26 |
AU734052B2 (en) | 2001-05-31 |
JP2001504329A (en) | 2001-04-03 |
KR20000052831A (en) | 2000-08-25 |
IL129397A0 (en) | 2000-02-17 |
EP0973394A4 (en) | 2005-03-30 |
NZ334568A (en) | 2000-04-28 |
BR9712587A (en) | 1999-10-26 |
CA2265523A1 (en) | 1998-05-07 |
NO991995D0 (en) | 1999-04-27 |
EE9900176A (en) | 1999-12-15 |
SA98180918A (en) | 2005-12-03 |
AU5093398A (en) | 1998-05-22 |
PL333169A1 (en) | 1999-11-22 |
AR009600A1 (en) | 2000-04-26 |
WO1998018323A1 (en) | 1998-05-07 |
SK34699A3 (en) | 2000-04-10 |
ID22065A (en) | 1999-08-26 |
IS5005A (en) | 1999-03-18 |
CN1235513A (en) | 1999-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991995L (en) | Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof | |
GB2181138B (en) | Recombinant alveolar surfactant protein | |
AR006188A1 (en) | "PHARMACEUTICAL COMPOSITION TO INHIBIT SERINPROTEASE ACTIVITY, IN VITRO METHOD TO INHIBIT SERINPROTEASE ACTIVITY AND METHOD TO PREPARE SUCH COMPOSITION". | |
ATE168719T1 (en) | OSTEOGENIC PEPTIDES | |
NZ332565A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
NO992158L (en) | Nucleic acid and amino acid sequences associated with Heliobacter Pylori and vaccine preparations thereof. | |
DK312787A (en) | POLYPEPTIDES, PROCEDURES FOR THEIR PREPARATION, DNA CODING THE POLYPEPTIDES, VECTORS CONTAINING SUCH REVENUES AND MEDICINALS CONTAINING POLYPEPTIDES | |
DK0463053T3 (en) | Preparation and use of anthelmintic agents and protective immunogens | |
DE3650035T2 (en) | THF compositions. | |
EP0317279A3 (en) | Peptides for use in the purification of factor viii | |
CA2004764A1 (en) | Ancrod proteins, their preparation and use | |
MX9709846A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics. | |
DK0540560T3 (en) | Ancrod-like proteins, their preparation and use | |
DK56995A (en) | Recombinant lymphotoxin variants | |
DK200200302A (en) | Recombinant polypeptides comprising the amino acid sequence of mature tissue factor inhibitor (TFI), polypeptide fragments thereof, expression vectors encoding them, host cells transformed therewith, and method for producing a ........ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |